Trial intelligence / Profile preview

Huamoyan Granules for acute and chronic knee joint synovitis

ChiCTR-TRC-13003025Phase 4Completed

Sponsor
Shuguang Hospital
Start
Oct 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of Huamoyan Keli in knee synovitis (2 arms), sponsored by Shuguang Hospital. Primary endpoint: Knee joint swelling improvement rate. Started Oct 2012; status: completed.

02

Drugs

Huamoyan Keli
03

Conditions

knee synovitis

Beyond the preview

Go deeper on ChiCTR-TRC-13003025.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-13003025.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call